68GA-FAPI PET/BT’de Normal Varyasyonlar ve Benign Bulgular

Rettig WJ, Chesa PG, Beresford HR, et al. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. Cancer Res. 1986 Dec;46(12 Pt 1):6406-12.
Rettig WJ, Garin-Chesa P, Beresford HR, et al. Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc Natl Acad Sci U S A. 1988 May;85(9):3110-4. doi: 10.1073/pnas.85.9.3110.
Park JE, Lenter MC, Zimmermann RN, et al. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999 Dec 17;274(51):36505-12. doi: 10.1074/jbc.274.51.36505.
Scanlan MJ, Raj BK, Calvo B, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5657-61. doi: 10.1073/pnas.91.12.5657.
Loktev A, Lindner T, Mier W, et al. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. J Nucl Med. 2018 Sep;59(9):1423-1429. doi: 10.2967/jnumed.118.210435.
Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev. 2020 Sep;39(3):783-803. doi: 10.1007/s10555-020-09909-3.
Gong W, Fu M, Zhang Y, et al. Progressive Multifocal Leukoencephalopathy Mimicking Malignancy on 68Ga-FAPI PET/CT: Potential Advantages of FAPI. Clin Nucl Med. 2022 May 1;47(5):430-432. doi: 10.1097/RLU.0000000000003976.
Hao B, Wu X, Pang Y, et al. 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT in the evaluation of tuberculous lesions. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):651-652. doi: 10.1007/s00259-020-04941-5.
Gong W, Yang X, Li L, et al. Elevated 68 Ga-FAPI Uptake by Primary Benign Intraosseous Meningioma. Clin Nucl Med. 2022 Nov 1; 47(11):994-995. doi: 10.1097/RLU.0000000000004347.
Peng D, Yang X, Yan Q, et al. Increased 68Ga-FAPI Uptake in Psammomatous Meningioma in a Patient With Gallbladder Cancer. Clinical Nuclear Medicine, 2022 Sep:10-1097. doi: 10.1097/RLU.0000000000004424.
Xu T, Zhang Y, Wu R, et al. 68Ga-DOTA-FAPI-04 PET/CT Imaging in a Case of Radioactive Iodine-Induced Chronic Parotitis. Clin Nucl Med. 2022 Dec 1;47(12):1082-1083. doi: 10.1097/RLU.0000000000004416.
Schmidkonz C, Rauber S, Atzinger A, et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020 Nov;79(11):1485-1491. doi: 10.1136/annrheumdis-2020-217408.
Luo Y, Pan Q, Yang H, et al. Fibroblast Activation Protein-Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT. J Nucl Med. 2021 Feb;62(2):266-271. doi: 10.2967/jnumed.120.244723.
Qin C, Song Y, Liu X, et al. Increased uptake of 68Ga-DOTA-FAPI-04 in bones and joints: metastases and beyond. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):709-720. doi: 10.1007/s00259-021-05472-3.
Zheng S, Lin R, Chen S, et al. Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT. Ann Nucl Med. 2021 Dec;35(12):1312-1320. doi: 10.1007/s12149-021-01673-w.
Wang Y, Yang X, Tian M, et al. Orbital Granulomatous Inflammation Mimicking Malignancy on 68Ga-FAPI PET/CT. Clin Nucl Med. 2022 Apr 1;47(4):380-381. doi: 10.1097/RLU.0000000000003982.
Rao Z, Wu J, Zhang C. A case of papillary thyroid carcinoma with Graves ophthalmopathy evaluated by 68Ga-FAPI PET/CT. Endocrine. 2022 Apr;76(1):243-244. doi: 10.1007/s12020-021-02962-0.
Kessler L, Ferdinandus J, Hirmas N, et al. Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis. J Nucl Med. 2022 Jun;63(6):890-896. doi: 10.2967/jnumed.121.262808.
Can C, Gündoğan C, Güzel Y, et al. 68Ga-FAPI Uptake of Thyroiditis in a Patient With Breast Cancer. Clin Nucl Med. 2021 Aug 1;46(8):683-685. doi: 10.1097/RLU.0000000000003637.
Liu H, Yang X, Liu L, et al. Clinical Significance of Diffusely Increased Uptake of 68Ga-FAPI in Thyroid Gland. Front Med (Lausanne). 2021 Nov 23;8:782231. doi: 10.3389/fmed.2021.782231.
Dabir M, Novruzov E, Mattes-György K, et al. Distinguishing Benign and Malignant Findings on [68 Ga]-FAPI PET/CT Based on Quantitative SUV Measurements. Mol Imaging Biol. 2022 Aug 23. doi: 10.1007/s11307-022-01759-5.
Pabst KM, Bartel T, Herrmann K, et al. Thyroiditis: A pitfall in Ga-68-FAPI-PET/CT? Nuklearmedizin. 2022:61(02) 195. DOI: 10.1055/s-0042-1746111
Liu H, Yang X, Liu L, et al. Clinical Significance of Diffusely Increased Uptake of 68Ga-FAPI in Thyroid Gland. Front Med (Lausanne). 2021 Nov 23;8:782231. doi: 10.3389/fmed.2021.782231
Zhou Y, He J, Chen Y. 68Ga-FAPI PET/CT imaging in a patient with thyroiditis. Endocrine. 2021 Aug;73(2):485-486. doi: 10.1007/s12020-021-02605-4.
Rao Z, Wu J, Zhang C. A case of papillary thyroid carcinoma with Graves ophthalmopathy evaluated by 68Ga-FAPI PET/CT. Endocrine. 2022 Apr;76(1):243-244. doi: 10.1007/s12020-021-02962-0.
Ou L, Wu J, Wu J, et al. Follicular Thyroid Adenoma Showing Avid Uptake on 68Ga-DOTA-FAPI-04 PET/CT. Clin Nucl Med. 2021 Oct 1;46(10):840-841. doi: 10.1097/RLU.0000000000003762.
Hotta M, Sonni I, Benz MR, et al. 68Ga-FAPI-46 and 18F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3736-3737. doi: 10.1007/s00259-021-05373-5.
Telo S, Farolfi A, Castellucci P, et al. A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae. Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2452-2453. doi: 10.1007/s00259-022-05720-0.
Tang W, Wu J, Yang S, et al. Organizing Pneumonia With Intense 68Ga-FAPI Uptake Mimicking Lung Cancer on 68Ga-FAPI PET/CT. Clin Nucl Med. 2022 Mar 1;47(3):223-225. doi: 10.1097/RLU.0000000000003855.
Liu H, Wang Y, Zhang W, et al. Elevated 68Ga-FAPI Activity in Splenic Hemangioma and Pneumonia. Clin Nucl Med. 2021 Aug 1;46(8):694-696. doi: 10.1097/RLU.0000000000003638.
Zhao L, Pang Y, Sun L, Lin Q, Chen H. Increased 68Ga-FAPI Uptake in the Pulmonary Cryptococcus and the Postradiotherapy Inflammation. Clin Nucl Med. 2022 Mar 1;47(3):243-245. doi: 10.1097/RLU.0000000000003873.
Hotta M, Benz MR, Allen-Auerbach MS, et al. High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):1088-1089. doi: 10.1007/s00259-021-05510-0.
Sviridenko A, Boehm A, di Santo G, et al. Enhancing Clinical Diagnosis for Patients With Persistent Pulmonary Abnormalities After COVID-19 Infection: The Potential Benefit of 68 Ga-FAPI PET/CT. Clin Nucl Med. 2022 Dec 1;47(12):1026-1029. doi: 10.1097/RLU.0000000000004437.
Röhrich M, Leitz D, Glatting FM, et al. Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study. J Nucl Med. 2022 Jan;63(1):127-133. doi: 10.2967/jnumed.121.261925.
Varasteh Z, Mohanta S, Robu S, et al. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04. J Nucl Med. 2019 Dec;60(12):1743-1749. doi: 10.2967/jnumed.119.226993.
Heckmann MB, Reinhardt F, Finke D, et al. Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease. Circ Cardiovasc Imaging. 2020 Sep;13(9):e010628. doi: 10.1161/CIRCIMAGING.120.010628.
Zhu W, Guo F, Wang Y, et al. 68Ga-FAPI-04 Accumulation in Myocardial Infarction in a Patient With Neuroendocrine Carcinoma. Clin Nucl Med. 2020 Dec;45(12):1020-1022. doi: 10.1097/RLU.0000000000003334.
Liu Y, Tao Y, Wang F, Huang Z. Mediastinum-type lung cancer on 68Ga-FAPI PET/CT with cardiac insufficiency as the first symptom. J Nucl Cardiol. 2021 Apr 6. doi: 10.1007/s12350-021-02601-1.
Finke D, Heckmann MB, Herpel E, et al. Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using 68Ga-FAPI PET/CT. Front Cardiovasc Med. 2021 Feb 25;8:614997. doi: 10.3389/fcvm.2021.614997.
Lin K, Chen X, Xue Q, et al. Diffuse uptake of [68Ga]Ga-FAPI in the left heart in a patient with hypertensive heart disease by PET/CT. J Nucl Cardiol. 2021 May 14. doi: 10.1007/s12350-021-02646-2.
Yuan T, Wang X. 68Ga-FAPI PET/MRI in Coronary Heart Disease. J Nucl Cardiol. 2021 Jul 6. doi: 10.1007/s12350-021-02667-x.
Wang YL, Wang L, Dong Z, Yang MF. Cardiac fibroblast activation in Fabry disease on 18F-fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging. Eur Heart J Case Rep. 2022 Oct 18;6(11):ytac419. doi: 10.1093/ehjcr/ytac419.
Siebermair J, Kessler L, Kupusovic J, et al. Cardiac fibroblast activation detected by 68Gallium-FAPI-46 positron emission tomography-magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis. Eur Heart J Case Rep. 2022 Jan 9;6(1):ytac005. doi: 10.1093/ehjcr/ytac005.
Niu N, Huo L, Zhang S, et al. Immune checkpoint inhibitor-associated cardiotoxicity detected by 68Ga-DOTATATE PET/CT and 68Ga-FAPI PET/CT. Eur Heart J Cardiovasc Imaging. 2022 Feb 22;23(3):e123. doi: 10.1093/ehjci/jeab189.
Guo W, Chen H. 68Ga FAPI PET/MRI in Cardiac Amyloidosis. Radiology. 2022 Apr;303(1):51. doi: 10.1148/radiol.211951.
Kessler L, Kupusovic J, Ferdinandus J, et al. Visualization of Fibroblast Activation After Myocardial Infarction Using 68Ga-FAPI PET. Clin Nucl Med. 2021 Oct 1;46(10):807-813. doi: 10.1097/RLU.0000000000003745.
Zhang M, Quan W, Zhu T, et al. [68Ga]Ga-DOTA-FAPI-04 PET/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling. Eur J Nucl Med Mol Imaging. 2022 Nov 3. doi: 10.1007/s00259-022-06015-0.
Qiao P, Wang Y, Zhu K, et al. Noninvasive Monitoring of Reparative Fibrosis after Myocardial Infarction in Rats Using 68Ga-FAPI-04 PET/CT. Mol Pharm. 2022 Nov 7;19(11):4171-4178. doi: 10.1021/acs.molpharmaceut.2c00551.
Chen BX, Xing HQ, Gong JN, et al. Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension. Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1211-1222.
Gu Y, Han K, Zhang Z, et al. 68Ga-FAPI PET/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study. J Nucl Cardiol. 2022 Mar 23. doi: 10.1007/s12350-022-02952-3.
Wang L, Zhang Z, Zhao Z, et al. 68Ga-FAPI right heart uptake in a patient with idiopathic pulmonary arterial hypertension. J Nucl Cardiol. 2022 Jun;29(3):1475-1477. doi: 10.1007/s12350-020-02407-7.
Wang G, Yang Q, Wu S, et al. Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET/CT. Eur J Nucl Med Mol Imaging. 2022 Sep 29. doi: 10.1007/s00259-022-05984-6.
Dendl K, Koerber SA, Adeberg S, et al. Physiological FAP-activation in a postpartum woman observed in oncological FAPI-PET/CT. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2059-2061. doi: 10.1007/s00259-021-05203-8.
Xu T, Wang W, Yang Cet al. 68Ga-DOTA-FAPI-04 Uptake of Accessory Breast in a Patient With Breast Cancer. Clin Nucl Med. 2022 Jun 1;47(6):564-565. doi: 10.1097/RLU.0000000000004069.
Sonni I, Lee-Felker S, Memarzadeh S, et al. 68Ga-FAPi-46 diffuse bilateral breast uptake in a patient with cervical cancer after hormonal stimulation. Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):924-926. doi: 10.1007/s00259-020-04947-z.
Lan L, Liu H, Wang Y, et al. The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [18F]FDG. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):963-979. doi: 10.1007/s00259-021-05522-w.
Beyhan E, Erol Fenercioğlu Ö, Yarikkaya E, et al. Chronic Gastritis Mimicking Malignancy on 68Ga-FAPI-04 PET/CT. Clin Nucl Med. 2022 Oct 14. doi: 10.1097/RLU.0000000000004439.
Zheng S, Lin R, Chen S, et al. Characterization of the benign lesions with increased 68Ga-FAPI-04 uptake in PET/CT. Ann Nucl Med. 2021 Dec;35(12):1312-1320. doi: 10.1007/s12149-021-01673-w.
Luo Y, Pan Q, Xu Het al. Active uptake of 68Ga-FAPI in Crohn's disease but not in ulcerative colitis. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1682-1683. doi: 10.1007/s00259-020-05129-7.
Zheng J, Lin K, Zheng S, et al. 68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis. Clin Nucl Med. 2022 Mar 1;47(3):239-240. doi: 10.1097/RLU.0000000000003917.
Alçın G, Tatar G, Şahin R, et al. Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis on 68 Ga-FAPI-04 and 18 F-FDG PET/CT. Clin Nucl Med. 2022 Aug 1;47(8):e557-e558.
Guo W, Pang Y, Yao L, et al. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1604-1617. doi: 10.1007/s00259-020-05095-0.
Shang Q, Fu L, Pang Y, et al. Increased [68 Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer. Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):415-416. doi: 10.1007/s00259-021-05519-5.
Zhao L, Gu J, Fu K, et al. 68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient. Clin Nucl Med. 2020 Oct;45(10):e430-e432. doi: 10.1097/RLU.0000000000003015.
Luo Y, Pan Q, Zhang W, Li F. Intense FAPI Uptake in Inflammation May Mask the Tumor Activity of Pancreatic Cancer in 68Ga-FAPI PET/CT. Clin Nucl Med. 2020 Apr;45(4):310-311. doi: 10.1097/RLU.0000000000002914.
Zhang X, Song W, Qin C, et al. Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas. Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2635-2641. doi: 10.1007/s00259-021-05194-6.
Wang R, Gao X, Han X, et al. Portal Biliopathy and Cavernous Transformation of the Portal Vein Revealed by 68Ga-FAPI PET/CT. Clin Nucl Med. 2022 Feb 1;47(2):161-163. doi: 10.1097/RLU.0000000000003815.
Liu H, Chen Z, Yang X, et al. Increased 68Ga-FAPI Uptake in Chronic Cholecystitis and Degenerative Osteophyte. Clin Nucl Med. 2021 Jul 1;46(7):601-602. doi: 10.1097/RLU.0000000000003621.
Gu B, Luo Z, He X, et al. 68Ga-FAPI and 18F-FDG PET/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor. Clin Nucl Med. 2020 Nov;45(11):865-867. doi: 10.1097/RLU.0000000000003279.
Zhou Y, Yang X, Liu H, et al. Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3493-3501. doi: 10.1007/s00259-021-05343-x.
Conen P, Pennetta F, Dendl K, et al. [68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3365-3372. doi: 10.1007/s00259-021-05660-1.
Guo YH, Yang MF. Increased 18F-ALF-NOTA-FAPI and 18F-FDG Uptake in Renal Angiomyolipoma. Clin Nucl Med. 2022 Mar 1;47(3):e306-e310. doi: 10.1097/RLU.0000000000004022.
Hu Z, Yang X, You Z, et al. Increased 68Ga-FAPI Uptake in Active Atherosclerotic Plaque. Clin Nucl Med. 2022 Jun 1;47(6):545-546. doi: 10.1097/RLU.0000000000004103.
Yang Q, Zhang Z, Li M, et al. Increased 68Ga-FAPI Uptake of Symptomatic Intracranial Atherosclerotic Plaque Revealed by PET/MR. Clin Nucl Med. 2022 May 1;47(5):469-470.
Wu S, Pang Y, Zhao L, et al. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis. Clin Nucl Med. 2021 Oct 1;46(10):847-849. doi: 10.1097/RLU.0000000000003692.
Gündoğan C, Güzel Y, Can C, et al. False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer. Clin Nucl Med. 2021 Aug 1;46(8):e433-e435. doi: 10.1097/RLU.0000000000003594.
Elboga U, Sahin E, Kus T, et al. Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer. Ann Nucl Med. 2021 Dec;35(12):1321-1331. doi: 10.1007/s12149-021-01672-x.
Wang Y, Wu J, Liu L, et al. 68Ga-FAPI-04 PET/CT Imaging for Fibrous Dysplasia of the Bone. Clin Nucl Med. 2022 Jan 1;47(1):e9-e10. doi: 10.1097/RLU.0000000000003896.
Liu H, Fu W, Yang X, Chen Y. Increased 68Ga-FAPI Uptake in Avascular Necrosis of Femoral Head in a Patient With Nasopharyngeal Carcinoma. Clin Nucl Med. 2022 May 1;47(5):449-450. doi: 10.1097/RLU.0000000000003996.
Wang Y, Wang R, Qi E, et al. Multiple pseudotumors after ceramic-on-ceramic total hip arthroplasty revealed by [68Ga]Ga-FAPI-04 PET/CT. Eur J Nucl Med Mol Imaging. 2022 Oct 17. doi: 10.1007/s00259-022-05993-5.
Li X, Zhao Q, Luo Q, et al. The Manifestation of a Patient With Myelofibrosis in 68Ga-DOTA-FAPI-04 PET/CT Mimicking "Super Bone Imaging". Clin Nucl Med. 2022 Dec 1;47(12):1056-1058. doi: 10.1097/RLU.0000000000004427.
Gong W, Yang X, Mou C, et al. Bone Tuberculous Granulomatous Inflammation Mimicking Malignancy on 68Ga-FAPI PET/CT. Clin Nucl Med. 2022 Apr 1;47(4):348-349. doi: 10.1097/RLU.0000000000003990.
Gong W, Chen S, He L, et al. Intense 68Ga-FAPI Uptake in a Patient With Myositis Ossificans: Mimicking Bone Malignancy. Clin Nucl Med. 2022 Jul 1;47(7):638-639. doi: 10.1097/RLU.0000000000004213.
Dorst DN, Rijpkema M, Buitinga M, et al. Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy. Rheumatology (Oxford). 2022 Jul 6;61(7):2999-3009. doi: 10.1093/rheumatology/keab664.
Luo Y, Pan Q, Yang H, et al. Inflammatory Arthritis Induced by Anti-Programmed Death-1 Shown in 68Ga-FAPI PET/CT in a Patient With Esophageal Carcinoma. Clin Nucl Med. 2021 May 1;46(5):431-432. doi: 10.1097/RLU.0000000000003608.
Cheung SK, Chen S, Wong YH, et al. Diagnosis of Seronegative Rheumatoid Arthritis by 68 Ga-FAPI PET/CT. Nucl Med Mol Imaging 2022 Oct 20. https://doi.org/10.1007/s13139-022-00779-x
Zheng J, Chen H, Lin K, et al. [68Ga]Ga-FAPI and [18F]FDG PET/CT images in a patient with juvenile polymyositis. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2051-2052. doi: 10.1007/s00259-020-05185-z.
Hayrapetian A, Girgis MD, Yanagawa J, et al. Incidental Detection of Elastofibroma Dorsi With 68Ga-FAPI-46 and 18F-FDG PET/CT in a Patient With Esophageal Cancer. Clin Nucl Med. 2021 Feb 1;46(2):e86-e87. doi: 10.1097/RLU.0000000000003218..
Yang X, Liu H, You Z, et al. Increased 68Ga-FAPI Uptake in Intramuscular Gluteal Hematoma in a Patient With Hemophagocytic Syndrome. Clin Nucl Med. 2021 Dec 1;46(12):1022-1023. doi: 10.1097/RLU.0000000000003771.